Tg(tetO-TGFB1*C223S*C225S)1Glk
Transgene Detail
|
|
| Symbol: |
Tg(tetO-TGFB1*C223S*C225S)1Glk |
| Name: |
transgene insertion 1, Adam Glick |
| MGI ID: |
MGI:3815091 |
| Synonyms: |
tetOTGFB1 |
| Transgene: |
Tg(tetO-TGFB1*C223S*C225S)1Glk Location: unknown
|
| Alliance: |
Tg(tetO-TGFB1*C223S*C225S)1Glk page
|
|
| Strain of Origin: |
Not Specified
|
|
| Transgene Type: |
|
Transgenic (Inducible, Inserted expressed sequence) |
| Inducer: |
|
doxycycline/tetracycline |
| Mutation: |
|
Insertion
|
| |
|
Mutation details: The porcine TGFbeta1 (TGFB1) cDNA containing a double mutation where cysteines at positions 223 and 225 converted to serines is driven by a heptameric tetO sequence and a CMV minimal promoter. The construct also contains a beta-globin intron. Founders were identified by Southern blotting. Mice express the porcine TGFB1 constitutively as a result of the two mutations. TGFB1 expression can be suppressed by crossing this line with a line expressing the tTA transactivator and maintaining pregnant females on a doxycycline-containing water supply.
(J:70670)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
| Original: |
J:70670 Liu X, et al., Conditional epidermal expression of TGFbeta 1 blocks neonatal lethality but causes a reversible hyperplasia and alopecia. Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9139-44 |
| All: |
7 reference(s) |
|